The Clinical Significance of HER2+ Breast Cancer and Opportunities for Improved Outcomes

Insights from ESMO Breast 2024 Annual Meeting
S

ESMO Breast 2024 Panel Discussion: "Key Updates in Breast Cancer"

By Insights from ESMO Breast 2024 Annual Meeting FEATURING Sara Tolaney, Hope Rugo
By Insights from ESMO Breast 2024 Annual Meeting FEATURING Sara Tolaney, Hope Rugo
847 views
June 10, 2024
0 Comments
Login to view comments. Click here to Login
13:28
Stanford Medicine

ADCs in HR+ Advanced/Metastatic BC

Feat. M. Dolezal
20:46
Miami Cancer Institute Precision Oncology Symposium

HER2 Targeted Treatments in Lower BC Expression Ranges

Feat. I. Krop
21:20
Dana-Farber Cancer Institute

Older Adults With Breast Cancer: Research Updates

Feat. R. Freedman
23:07
Keck School of Medicine of USC

2024 Updates on the Future of ADCs in Breast Cancer

Feat. C. Geyer
20:31
OncoAlert

HER2+ mBC: Year-in-Review Including DESTINY Breast-03 & HER2CLIM…

Feat. S. Graff
05:02
Total Health

CNS Metastasis in Breast Cancer: Surgery & Radiation Considerati…

Feat. C. Santa-Maria
12:54
Total Health

Antibody Drug Conjugates: Highlights in Breast Cancer

Feat. K. Kalinsky
19:34
Keck School of Medicine of USC

Breast Cancer Oligometastases and Beyond

Feat. S. Chmura
15:26
Dana-Farber Cancer Institute

Antibody Drug Conjugates Highlights - mBC Series

Feat. H. Burstein
25:25
Alessia Pellerino

Treatment Strategies for Leptomeningeal Disease in HER2+ mBC: Addres…

29:40
Insights from 2023 SABCS

Year in Review: Metastatic Breast Cancer

Feat. M. Mac Gregor
03:28
Total Health

62 y/o With HER2+ mBC Who Underwent 2L TDXd Therapy: Case Presentati…

Feat. P. Sharma, M. Telli, K. Kalinsky
21:31
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Summary: "Community Oncologists Highlights&quo…

Feat. S. Tolaney, H. Rugo
12:07
Sara Tolaney

ESMO 2024 Noteworthy Abstracts in Breast Cancer

Feat. H. Rugo
13:05
V.K. Gadi

Key Updates and Insights on HER2+ Breast Cancer

19:30
Elisa Agostinetto

The Evolving Landscape of Treatment Options in HER2+ mBC

04:04
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Updated Survival Data in DESTINY-Breast03…

Feat. E. Hamilton
10:31
Sarah Premji

Treatment Selection in 2L for HER2+ MBC: Updated Guidelines, Safety …

11:57
V.K. Gadi

Clinical Guidance on the Management and Monitoring of T-DXd-Related …

10:09
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatmen…

Feat. H. Rugo
12:13
UChicago Medicine

Trastuzumab Deruxtecan in HER2+ mBC

Feat. H. Rugo
17:48
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Frontiers in Breast Cancer Brain Metastasis: ADC Effectiveness in th…

Feat. S. Modi
20:19
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Chemoprevention in Brain Mets: Breast Cancer Perspective

Feat. A. Zimmer